Adjuvant Stromal Amphotericin B Injection for Late-Onset DMEK Infection

Conclusions: Medical therapy, including systemic and intrastromal application, is a viable initial treatment option for late-onset, presumed yeast interface keratitis in patients who have undergone DMEK.

Source: Cornea - November 3, 2017 Category: Opthalmology Tags: Case Report Source Type: research